News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Talha Badar: Clinical trials utilizing upfront venetoclax for AML
Talha Badar/X
Mar 4, 2025, 05:28

Talha Badar: Clinical trials utilizing upfront venetoclax for AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared a post on X:

“Highlighting key data points on clinical trials utilizing upfront venetoclax for intensive eligible treatment naive AML.

By no means a cross-trial comparison.”

Talha Badar: Clinical trials utilizing upfront venetoclax for AML

AML cancer clinical trials fight against cancer Global fight against cancer Mayo Clinic OncoDaily Oncology Talha Badar venetoclax
Special Coverage
Blog
Mar 4, 2025, 05:28
Talha Badar: Clinical trials utilizing upfront venetoclax for AML
Science
Mar 4, 2025, 05:27
Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy
Science
Mar 4, 2025, 05:25
Edward Christopher Dee: Cancer incidence and mortality estimates in 2022 in southeast Asia
Blog
Mar 4, 2025, 05:25
Ashish M. Kamat: The 8th edition of Rapid Fire Debates in Bladder Cancer at EAU 2025
Blog
Mar 4, 2025, 05:24
Ginny Mason: Financial Toxicity in cancer care continues to be challenge for patients
Blog
Mar 4, 2025, 05:24
11th ESO Prostate Cancer Observatory during the 40th Annual EAU Congress
Blog
Mar 4, 2025, 05:23
Shivani Modi: Disparities in Colorectal Cancer Screening Rates
Science
Mar 4, 2025, 05:22
Rahul Banerjee: Teclistamab and Talquetamab are approved in Mexico for triple-class exposed
Science
Mar 4, 2025, 05:19
Vladmir C. Cordeiro de Lima: Frequency and characteristics of ERBB2 mutations in Latin American NSCLC patients
Blog
Mar 4, 2025, 05:18
Wafaa M Rashed: Access to medicine is just one piece of the puzzle
Blog
Mar 4, 2025, 04:58
Alba Fiorentino: The first Vision RT Ltd Italian User Meeting
Blog
Mar 4, 2025, 04:35
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians